CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,341,159
- in 16 filings, $529K under 10b5-1 plans
Net −$2,341,159. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | Krishnamohan Neha Chief Financial Officer | Shares withheld for taxes | −5,813 | $2.75 | $16K | 102,846 |
| 2025-08-15 | Bush Jennifer COO, CLO, Secy, Compliance Off | Shares withheld for taxes | −6,409 | $2.75 | $18K | 151,103 |
| 2025-08-15 | Horan Christopher Chief Tech Operations Officer | Shares withheld for taxes | −3,577 | $2.75 | $10K | 80,082 |
| 2025-06-24 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Director Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2025-06-24 | Stoppel Laura Director | Grant or award · Director Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2025-06-24 | MOORE ALISON Director | Grant or award · Director Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2025-06-24 | Baker Daniel G. Director | Grant or award · Director Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2025-06-24 | HOUGEN ELIZABETH L Director | Grant or award · Director Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2025-06-24 | Miralles Gines Diego Director | Grant or award · Director Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2025-06-24 | DANIELS BRIAN Director | Grant or award · Director Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2025-05-15 | Aslan Fred President and CEO | Shares withheld for taxes 10b5-1 | −4,472 | $2.13 | $10K | 412,193 |
| 2025-05-15 | Raymon Heather SVP, Research and Development | Shares withheld for taxes | −745 | $2.13 | $2K | 42,605 |
| 2025-05-15 | Krishnamohan Neha Chief Financial Officer | Shares withheld for taxes | −1,341 | $2.13 | $3K | 108,659 |
| 2025-05-15 | Bush Jennifer COO, CLO, Secy, Compliance Off | Shares withheld for taxes | −1,937 | $2.13 | $4K | 157,512 |
| 2025-05-15 | Horan Christopher Chief Tech Operations Officer | Shares withheld for taxes | −1,341 | $2.13 | $3K | 83,659 |
| 2025-04-08 | Banerjee Subhashis Chief Medical Officer | Grant or award | +50,000 | 50,000 | ||
| 2025-04-08 | Banerjee Subhashis Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2025-03-05 | Aslan Fred President and CEO | Grant or award | +200,000 | 416,665 | ||
| 2025-02-26 | Raymon Heather SVP, Research and Development | Grant or award | +33,350 | 43,350 | ||
| 2025-02-26 | Graef Thorsten Chief Medical Officer | Grant or award | +60,000 | 80,000 |
Page 7 of 11 · 203 trades